Business: Avantor is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The company's segments include ...

Avantor is trading at its lowest valuation since 2019, attracting significant management buying of the stock, with clear chart accumulation trends since April. AVTR has been aggressively repaying debt ...

Avantor Inc. (NYSE:AVTR) stock is trading after reporting worse-than-expected third-quarter 2025 adjusted earnings of 22 cents, below the consensus of 23 cents. The life science tools company reported ...

Full-year 2025 organic revenue growth is now expected at negative 3.5% to negative 2.5%, with reported revenue growth of negative 4% to negative 3% after accounting for FX and divestiture impacts.

11 analysts have shared their evaluations of Avantor (NYSE:AVTR) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a condensed view of their ...

Avantor (NYSE:AVTR) is gearing up to announce its quarterly earnings on Friday, 2024-10-25. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...